Literature DB >> 2006694

Familial, obstetric, and other clinical correlates of minor physical anomalies in schizophrenia.

E O'Callaghan1, C Larkin, A Kinsella, J L Waddington.   

Abstract

OBJECTIVE: This study investigated possible antecedents of minor physical anomalies in schizophrenia, particularly in terms of obstetric and genetic factors, and demographic, clinical and cognitive correlates of such anomalies in schizophrenia.
METHOD: Forty-one outpatients satisfying the DSM-III criteria for schizophrenia were examined for minor physical anomalies by using the Waldrop scale. These subjects were drawn from a group of 45 such patients whose cognitive function had been previously evaluated with Trail Making Tests A and B and whose biological mothers had been interviewed for any history of obstetric complications or family history of schizophrenia.
RESULTS: Linear multiple regression analysis showed that higher scores for minor physical anomalies were associated with impaired cognitive flexibility on Trail Making Test B, family history of schizophrenia in a first-degree relative, maternal history of obstetric complications, smaller number of siblings, later position in the birth order, and male sex. A family history of schizophrenia was particularly associated with abnormalities of the mouth. The association between minor physical anomalies in the patients and obstetric complications in their mothers appeared to be confined to instances in which the mother had a history of bleeding in early pregnancy.
CONCLUSIONS: Minor physical anomalies indicate early dysmorphogenesis in schizophrenia, particularly in males, which appears to be associated more reliably with genetic rather than obstetric factors and with cognitive impairment.

Entities:  

Mesh:

Year:  1991        PMID: 2006694     DOI: 10.1176/ajp.148.4.479

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  20 in total

1.  Patterns of dysmorphic features in schizophrenia.

Authors:  L E Scutt; E W Chow; R Weksberg; W G Honer; A S Bassett
Journal:  Am J Med Genet       Date:  2001-12-08

2.  Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia.

Authors:  Vidyulata Kamath; Paul J Moberg; Raquel E Gur; Richard L Doty; Bruce I Turetsky
Journal:  Behav Neurosci       Date:  2011-12-12       Impact factor: 1.912

Review 3.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

Review 4.  The pathobiology of lost human potential: schizophrenia as a neurodevelopmental disorder.

Authors:  J L Waddington
Journal:  Ir J Med Sci       Date:  1991-12       Impact factor: 1.568

Review 5.  22q11 deletion syndrome: a genetic subtype of schizophrenia.

Authors:  A S Bassett; E W Chow
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

Review 6.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

7.  Minor physical anomalies in schizophrenia: a meta-analysis.

Authors:  Seth M Weinberg; Elizabeth A Jenkins; Mary L Marazita; Brion S Maher
Journal:  Schizophr Res       Date:  2006-10-31       Impact factor: 4.939

Review 8.  Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia?

Authors:  Michael T Compton; Elaine F Walker
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

9.  Depth of the olfactory sulcus: a marker of early embryonic disruption in schizophrenia?

Authors:  Bruce I Turetsky; Patrick Crutchley; Jeffrey Walker; Raquel E Gur; Paul J Moberg
Journal:  Schizophr Res       Date:  2009-09-20       Impact factor: 4.939

10.  Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study.

Authors:  E O'Callaghan; T Gibson; H A Colohan; P Buckley; D G Walshe; C Larkin; J L Waddington
Journal:  BMJ       Date:  1992-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.